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For the last decades a growth of frequency and heaviness of aller­
gic broncho-obstructive diseases (ABOD) has been registered in near­
ly all developed countries. Etiology, pathology and mechanisms of 
development of these diseases are not clear enough by now and that 
is why the methods of their diagnosis, treatment and rehabilitation are 
not sufficiently worked out, too. The purpose of our work is to make 
an attempt for improvement of diagnosis, treatment and rehabilitation 
of ABOD. 
For 9 years, 8132 adults with ABOD were studied. Skin allergic 
tests and functional breathing tests were made to all of them. Bronchial 
provocations with specific and non-specific antigens and immune tests 
were made to some of the patients. The patients were divided in 4 
groups. I s t group of 870 patients treated with bronchodilators: xan­
thines, -sympathomimetics/ cholinolytics, Ca-antagonists and corti­
costeroids in 'order not only to compare their effect but in 
immunopharmacological aspect, too. In I I n d group of 6089 patients 
specific immunotherapy was applied separately or in combination with 
intal, zaditen, respivax, levamisol and physical methods. In order to 
project the specific immunotherapy the titer of specific IgG antibodies 
in the serum of patients was examined. The patients from the I I I r d group 
(349) were treated with different immunomodulators: levamisol, respi­
vax, dipiridamol, Gamma A and vitamins А, В, C. In the IV t h group 
together with the bronchodilators were applied physical methods: 
LASER puncture and interference current. 
After comparing the different bronchodilators it turned out that the 
clinical effect of theophylin and agonists is greater than that of choli­
nolytics. The Caantagonists can not be used as monotherapy in pa­
tients with expressed bronchospasm. But they can be used for patients 
with expressed rhythmical disturbances and combined pathology. The 
immunological activity of patients treated for a long period with bron­
chodilators was inhibited and the inhibition was greater after treatment 
with corticosteroids. After successful specific immunotherapy the pha­
gocytosis is stimulated and the number of patients with cellmediated 
immune deficiency decreases. We found a correlation between the in-
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crease of the specific IgG antibodies in the serum of the patients and 
the clinical effectiveness of the specific immunotherapy in 93,7% of the 
patients. The immunotherapy is more effective when it is combined 
with other drugs and with psychic and physical rehabilitation. 
Among the immunomodulators with greatest effectiveness were 
levamisol and respivax. They reduced the frequency, the duration and 
severity of recurrences and the number of bronchodilators. All the pa­
tients treated with physical methods got better. 82% of the patients 
treated with LASER puncture did not get any asthma attack and in the 
order 18% the attacks became less frequent. The number of the bron­
chodilators also was reduced and in 10,8% of cases they were discon­
tinued. The treatment with interference current also was with excellent 
effect in 87,5% of the cases. A reduction of therapy with other me­
dicines was attained in 56,2%. Our findings are similar to the results of 
other authors (1-6). 
As a conclusion we can say that bronchial provocations with spe­
cific and non-specific antigens work out the details of diagnosis of 
ABOD. Our findings of correlation between the increase of specific IgG 
antibodies and the clinical effectiveness of specific immunotherapy 
show that it can be used for an impartial assessment of the effective­
ness of immunotherapy. The inclusion of immunomodulators in the 
complex treatment of the patients reduces the frequency, the duration 
and the severity of recurrences and enhances the effectiveness of the 
desobstructive therapy. The physical methods are with significant ther­
apeutic effectiveness in the patients with ABOD. 
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